Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs
Conclusion With the increasing number of large sample size breast cancer cohorts, an exploratory analysis of genes that are consistently enriched in TN sharing common promoter motifs allows for the identification of possible therapeutic targets with extensive validation in patient derived data sets.
Source: Meta Gene - Category: Genetics & Stem Cells Source Type: research